Brazilian Beach Scams Debit Card Overcharges Cost Tourists Thousands Colombia Violence Claims at Least 52 Lives Raising Security and Economic Concerns US and Iran Signal Potential Progress but Remain at Odds Over Key Issues Bureau of Prisons Adopts AI Technology Signaling Shift in Federal Facility Management Charter Communications Enhances Offer for Liberty Broadband in New Buyout Deal Genpacts Tyagarajan Predicts AIDriven Job Reductions and Slower IT Hiring in India Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surges Past Expectations by 315 Stock Edges Lower KRMN Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Operational Challenges SABS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline AMCON Distributing Company DIT Q1 2026 Earnings Negative EPS of 234 Amid Challenging Operating Environment FITBI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency OLMA Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Pipeline Advances Carters Inc CRI Continues Slide as Stock Tests Key Support Near MultiYear Lows Beneficient Warrants BENFW Remain Flat at 001 as Trading Stalls Shoulder Innovations SI Slips 179 as Key Support Levels Are Tested Vir Biotechnology VIR Rallies 495 Key Levels to Watch After Move to 955 Bloom Energy BE Faces Selling Pressure as Stock Retreats from Resistance Zone GRDX Q3 2024 Earnings Earnings Miss by Wide Margin Amid Transition Challenges SNDL Q1 2026 Earnings NarrowerThanExpected Loss as Company Navigates Cannabis Market Challenges Compass Therapeutics Q1 2026 Earnings Narrowerthanexpected Loss Fuels Investor Optimism Maravai LifeSciences Q1 2026 Earnings EPS Surprise Beats Street but Stock Slips Amid Revenue Disclosures MCHB Q1 2026 Earnings Profit Miss Sends Shares Lower Amid Margin Pressures Comstock Inc LODE Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Discipline Alibaba Unveils Enhanced Zhenwu AI Chip and NextGeneration Large Language Model Magyar Bancorp Inc MGYR Q4 2025 Earnings Bank Reports EPS of 040 Amid Quiet Quarter Clover Health CLOV Slips Below Key Level as Selling Pressure Persists